Search Results

Displaying Results 1-25 of 602 "'CR'"

Mar 31, 2026, 15:00 ET Top Crunch Fitness franchisee CR Fitness launches Conquer Challenge member fitness competition

operates 95 clubs across Florida, Georgia, North Carolina, Texas, and Tennessee, with further growth plans in Arizona.About CR Fitness HoldingsCR Fitness Holdings is the leading franchisee of Crunch Fitness. The company rapidly expanded its club footprint throughout Florida, Georgia,

More news about: CR Fitness Holdings, LLC.


Mar 31, 2026, 13:45 ET Leading Crunch Fitness Franchisee Opens Its 94th Location, Bringing State-of-the-Art Fitness to Pompano Beach

with plans to expand into Arizona.About CR Fitness Holdings CR Fitness Holdings is the leading franchisee of Crunch Fitness, and led by a management team with over 150 years of combined experience in the fitness industry. CR Fitness is on track to operate 110 locations nationwide

More news about: CR Fitness Holdings


Mar 31, 2026, 12:25 ET Radon Medical Imaging Announces Acquisition of Majestic Medical Solutions

refurbished medical imaging equipment including, but not limited to: MRI, PET/CT, fluoroscopy, mammography, cardiac cath lab, urology, digital DR and CR, C-arm, general radiographic (X-Ray) and select PACS systems. Radon Medical Imaging was founded in 1976 and is headquartered in Charleston, West Virginia,

More news about: Radon Medical Imaging


Mar 31, 2026, 08:35 ET Standardizing Sustainability: ChinaAMC Leads the Way in Public REITs ESG disclosure

includes ChinaAMC Yuexiu Expressway REIT, ChinaAMC Beijing Affordable Housing REIT, ChinaAMC CR Youchao REIT, ChinaAMC Hefei High-Tech REIT, ChinaAMC Heda High-Tech REIT, ChinaAMC Jinmao Commercial REIT, ChinaAMC CR Commercial REIT, ChinaAMC Joy City Commercial REIT, ChinaAMC CapitaLand Commercial REIT,

More news about: ChinaAMC


Mar 30, 2026, 15:00 ET Top Crunch Fitness Franchisee Heads West: Arizona Expansion Signals Aggressive Growth Strategy

Dyer, Tony Scrimale, and Jeff Dotson - has built CR Fitness into a growth-driven organization known for disciplined expansion, strong unit performance, and community impact.About CR Fitness Holdings and Southwest Fitness Holdings LLCCR Fitness Holdings, is the leading franchisee of

More news about: CR Fitness Holdings, LLC.


Mar 30, 2026, 06:30 ET Pedestrian Protection System Market worth $8.56 billion by 2033 | MarketsandMarkets™

over 40 m, and critical response times for AEB systems, which are being integrated into vehicles like the Ford F-150, Toyota Highlander, and Honda CR-V.Inquire Before Buying: 

More news about: MarketsandMarkets


Mar 27, 2026, 02:05 ET Fenesta hosts 'The Fenesta Conclave' to connect design communities across key Indian markets

commercial projects.About Fenesta Building System: Fenesta is India's largest windows and doors brand and a part of the Rs. 12,741 cr conglomerate DCM Shriram Ltd. Its installations across more than 5,00,000 homes have already crossed the magical 5 million mark. Empowered with the knowledge

More news about: Fenesta


Mar 26, 2026, 09:54 ET Keymed Biosciences Announces 2025 Annual Results and Business Updates

in relapsed/refractory multiple myeloma (RRMM) showed an objective response rate (ORR) of 95.2% in the target dose group, with a ≥ complete response (≥CR) rate of 76.2%, a minimal residual disease (MRD) negativity rate of 100%, and a 12-month progression-free survival (PFS) rate of 95.2%. The Phase III

More news about: Keymed


Mar 26, 2026, 09:50 ET Top Crunch Fitness Franchisee CR Fitness Holdings Announces One-Day Only Cyber Sale for Crunch Pompano Beach

and Tennessee - with plans to expand into Arizona. The company is on track to operate 110 locations by the end of 2026.About CR Fitness Holdings LLCCR Fitness Holdings, LLC is the leading and fastest growing franchisee of Crunch Fitness, currently serves over one million members, and

More news about: CR Fitness Holdings, LLC.


Mar 26, 2026, 09:32 ET CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

among the top two globally. In combination with R-CHOP as a first-line treatment for DLBCL (at doses of 50–90 μg/kg), the CR rate exceeds 90%, and the ORR reaches 100%. Additionally, the combination cohort for later-line DLBCL

More news about: CStone Pharmaceuticals


Mar 25, 2026, 05:00 ET Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMD

with a construct encoding mini-CR1, a truncated and secreted form of Complement Receptor 1 that can modulate both the alternative and classical complement pathways. Subretinal delivery of CTx001 enables local retinal production of mini-CR1, whilst the small size of mini-CR1 may support penetration across

More news about: Complement


Mar 24, 2026, 13:38 ET 科倫博泰公佈2025年業績:多款產品成功上市,階梯式研發管線蓄勢待發

與Crescent Biopharma合作:2025年12月,該公司與Crescent Biopharma就SKB105/CR-003及SKB118(一種PD1 x VEGF雙抗,亦稱CR-001)達成戰略合作。根據合作,該公司授予Crescent Biopharma在美國、歐洲及大中華區以外的所有其他市場研究、開發、生產和商業化SKB105/CR-003的獨家權利。作為回報,公司從Crescent Biopharma獲得在大中華區研究、開發、生產和商業化SKB118/CR-001的獨家權利。2026年1月,Crescent Biopharma宣佈其用於治療晚期實體瘤的SKB118新藥臨床試驗申請已獲FDA批准,啟動全球ASCEND

More news about: 科倫博泰


Mar 23, 2026, 22:31 ET KELUN-BIOTECH ANNOUNCED 2025 ANNUAL RESULTS: MULTIPLE PRODUCTS SUCCESSFULLY LAUNCHED WITH TIERED PIPELINE READY FOR TAKE-OFF

entered into a strategic collaboration for SKB105/CR-003 and SKB118 (a PD1 x VEGF bsAb, also known as CR-001). Under the collaboration, the company granted Crescent Biopharma exclusive rights to research, develop, manufacture and commercialize SKB105/CR-003 in the United States, Europe and all other markets

More news about: Kelun-biotech


Mar 23, 2026, 20:00 ET The Phase 3 Registration STAR Study of Efdamrofusp Alfa (IBI302) Met its Primary Endpoint, Making it the First Self-developed Extended-interval Treatment for nAMD in China

clinical study (STAR) of efdamrofusp alfa injection (recombinant human vascular endothelial growth factor receptor [VEGFR]/human complement receptor 1 [CR1] fusion protein, R&D code: IBI302) in the Chinese patients with neovascular age-related macular degeneration (nAMD) has met the 52-week primary endpoint.

More news about: Innovent Biologics


Mar 23, 2026, 11:00 ET Less Mess, More Done: 3 VEVOR Bestsellers for Spring

65-piece set includes both SAE and metric deep and standard sockets, making it useful across a wide range of repair and maintenance tasks. Made from Cr-V industrial-grade alloy steel, the sockets are built for repeated impact use, while the 6-point hex drive design helps reduce wear on fasteners and

More news about: VEVOR


Mar 23, 2026, 09:00 ET Mês da Mulher: entre planos, carreira e maternidade, mulheres enfrentam a infertilidade

https://mma.prnewswire.com/media/2939006/Foto_divulga__o_Cr_dito_Future_Fertil_ilty_divulga__o.jpg

More news about: Future Fertility


Mar 20, 2026, 14:30 ET HONEYWELL ANNOUNCES PRICING OF ITS DEBT TENDER OFFERS

CUSIP: 438516CR5ISIN: US438516CR55

More news about: Honeywell


Mar 20, 2026, 12:00 ET Carnival Corporation & plc Announces Its Intention to Voluntarily Delist Its 1.000% Senior Unsecured Notes Due 2029 From the NYSE and Its 7.875% Debentures Due 2027 From the LSE and Relist the Notes and Debentures on the International Stock Exchange

www.seabourn.com.Carnival Corporation LEI Number: F1OF2ZSX47CR0BCWA982Carnival plc LEI Number: 4DR1VPDQMHD3N3QW8W951 Carnival Corporation substituted Carnival plc as issuer of the Debentures

More news about: Carnival Corporation & plc


Mar 20, 2026, 11:00 ET Only $200 in the Budget? These Three High-Value Tools Can Still Help Refresh Your Home

Built to last, the 65-piece set is crafted from rugged Cr-V industrial-grade alloy steel, giving homeowners more confidence when tackling stubborn bolts, garage fixes, and routine auto repairs. Its hexagonal

More news about: VEVOR


Mar 20, 2026, 08:00 ET HONEYWELL ANNOUNCES EARLY PARTICIPATION RESULTS AND UPSIZING OF ITS DEBT TENDER OFFERS

CUSIP: 438516CR5ISIN: US438516CR55

More news about: Honeywell


Mar 19, 2026, 16:00 ET Curis Provides Fourth Quarter 2025 Business Update

showed results for 2 patients who had previously progressed on a BTKi. Adding emavusertib to their ibrutinib treatment resulted in 1 complete response (CR) and 1 stable disease (SD) with a 38% reduction in disease burden.  Curis continues to enroll PCNSL patients in the Company's TakeAim Lymphoma

More news about: Curis, Inc.


Mar 19, 2026, 10:16 ET Kelley Blue Book Announces 2026 Best Resale Value Award Winners

COMPACT SUV: Honda CR-VMINIVAN:

More news about: Kelley Blue Book


Mar 19, 2026, 10:00 ET Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care

half of 2026. The company's pivotal LEGEND cohort of 125 BCG-unresponsive NMIBC patients demonstrated a 63% complete response rate at any time and a 62% CR rate at 6 months, while enGene Holdings closed Q1 with $312.5 million in cash and marketable securities."As data from LEGEND's pivotal

More news about: USA News Group


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.